Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BE1116 vs FFP in Complex Cardiovascular Surgery With Cardiopulmonary Bypass
NCT07094087Phase 3Recruiting
- Sponsor
- CSL Limited
- Start
- Sep 2025
- Primary completion
- Apr 2027
- Countries
- 4
01
Overview
A Phase 3 trial of balfaxar in coagulation factor deficiency, sponsored by CSL Limited. Started Sep 2025; status: recruiting.
02
Drugs
balfaxar
03
Conditions
coagulation factor deficiency
Beyond the preview
Go deeper on NCT07094087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07094087.